Spots Global Cancer Trial Database for human papilloma virus infection
Every month we try and update this database with for human papilloma virus infection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Oral HPV Infection in Young Men | NCT00897273 | Head and Neck C... Infection Precancerous Co... | comparative gen... gene expression... study of socioe... evaluation of c... study of high r... | 18 Years - 21 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused by HPV | NCT04002154 | Human Papilloma... Human Papilloma... Cervix Lesion | Papilocare vagi... | 30 Years - 65 Years | Procare Health Iberia S.L. | |
| Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection | NCT03677960 | HSIL, High-Grad... Human Papilloma... HIV Infection Anal Cancer Anus Neoplasm | Topical ABI-196... | 27 Years - | Antiva Biosciences | |
| Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine | NCT03542227 | Human Papilloma... | First-void urin... Blood draw | 16 Years - 55 Years | Universiteit Antwerpen | |
| e- Ab Sensor-based Real-time Detection of Oncogenic Human Papilloma Viruses | NCT01387997 | Cervical Cancer Human Papilloma... | Electrosensing ... | - | National Taiwan University Hospital | |
| Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas | NCT01539668 | Cervical Cancer... Human Papilloma... Human Papilloma... Prevention | - | Barretos Cancer Hospital | ||
| Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer | NCT01084083 | Head and Neck C... Precancerous Co... | cetuximab intensity-modul... Paclitaxel Cisplatin | 18 Years - | Eastern Cooperative Oncology Group | |
| Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males | NCT01209325 | Anal Cancer Nonneoplastic C... Penile Cancer Precancerous Co... | quadrivalent hu... laboratory biom... | 13 Years - 26 Years | AIDS Malignancy Consortium | |
| Community-Driven Cervical Cancer Prevention in Western Kenya | NCT02124252 | Human Papilloma... Carcinoma in Si... | Community-based... Community-based... | 25 Years - 65 Years | Duke University | |
| Immunogenicity of 9-valent HPV Vaccine | NCT05439083 | Human Papilloma... | 9-valent HPV va... | 9 Years - 18 Years | Instituto de Investigación Hospital Universitario La Paz | |
| Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening | NCT00977392 | Health Status U... Precancerous Co... | compliance moni... cervical Papani... educational int... screening quest... survey administ... colposcopy | 25 Years - | National Cancer Institute (NCI) | |
| Detection of High-Risk HPV in Urine and Cervical Swab Specimen Using HPV Diagnostic Kit (Bio Farma) | NCT06111911 | Human Papilloma... | HPV Diagnostic ... | 20 Years - 50 Years | PT Bio Farma | |
| Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070) | NCT01567813 | Human Papilloma... | 9 Years - 26 Years | Merck Sharp & Dohme LLC | ||
| A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine | NCT05694728 | Human Papilloma... | Recombinant Non... Recombinant Qua... | 20 Years - 45 Years | Beijing Health Guard Biotechnology, Inc | |
| Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens | NCT02634190 | Human Papilloma... | Thinprep® LBC APTIMA® HPV Ass... HR HC2® HPV DNA Colposcopy | 30 Years - 60 Years | Hologic Deutschland GmbH | |
| Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia | NCT01164722 | Anal Cancer Neoplasm of Unc... Nonneoplastic C... Precancerous Co... | clinical observ... infrared photoc... | 27 Years - | AIDS Malignancy Consortium | |
| Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County | NCT02067507 | Human Papilloma... | Tailored educat... Staff training ... Clinic-level re... | 9 Years - 70 Years | University of California, Los Angeles | |
| The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia | NCT00653146 | Cervical Cancer Precancerous Co... | Mindfulness-Bas... Healthy Lifesty... | 18 Years - | Fox Chase Cancer Center | |
| Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens | NCT02634190 | Human Papilloma... | Thinprep® LBC APTIMA® HPV Ass... HR HC2® HPV DNA Colposcopy | 30 Years - 60 Years | Hologic Deutschland GmbH | |
| Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV | NCT01946139 | Anal Cancer HIV Infection Human Papilloma... | comparison of s... laboratory biom... questionnaire a... quality-of-life... | 18 Years - | AIDS Malignancy Consortium | |
| Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia | NCT00054041 | Cervical Cancer Cervical Intrae... Human Papilloma... | HspE7 therapeutic con... laboratory biom... | 17 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia | NCT00054041 | Cervical Cancer Cervical Intrae... Human Papilloma... | HspE7 therapeutic con... laboratory biom... | 17 Years - | National Cancer Institute (NCI) | |
| Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia | NCT01164722 | Anal Cancer Neoplasm of Unc... Nonneoplastic C... Precancerous Co... | clinical observ... infrared photoc... | 27 Years - | AIDS Malignancy Consortium | |
| Folic Acid Clinical Trial for the Prevention of Cervical Cancer | NCT00703196 | Cervical Cancer Precancerous Co... | folic acid placebo | 19 Years - 120 Years | University of Alabama at Birmingham | |
| Diagnostic Cervical Conization for Persistent Infection or Integration of HPV | NCT05510830 | Human Papilloma... Human Papilloma... Cervical Intrae... Cervical Cancer Cervical Coniza... | diagnostic cerv... | 25 Years - 70 Years | Tongji Hospital | |
| Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men | NCT00919997 | Nonneoplastic C... Precancerous Co... | DNA analysis polymerase chai... fluorescence ac... questionnaire a... study of socioe... study of high r... | 18 Years - | AIDS Malignancy Consortium | |
| Reducing Abundance of Human Papilloma Virus in Women by Taking Probiotic | NCT05316064 | Human Papilloma... | probiotic placebo | 26 Years - | Universiti Sains Malaysia | |
| A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine | NCT05694728 | Human Papilloma... | Recombinant Non... Recombinant Qua... | 20 Years - 45 Years | Beijing Health Guard Biotechnology, Inc | |
| Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer | NCT02258659 | Human Papilloma... Stage III Squam... Stage IVA Squam... Stage IVB Squam... | paclitaxel albu... carboplatin radiation thera... paclitaxel fluorouracil hydroxyurea cisplatin laboratory biom... quality-of-life... | 18 Years - | University of Chicago | |
| Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer | NCT02048020 | Human Papilloma... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage IV Squamo... Stage IV Verruc... Stage IVA Squam... Stage IVA Squam... Stage IVA Verru... Stage IVB Squam... Stage IVB Squam... Stage IVB Verru... Stage IVC Squam... Stage IVC Squam... Stage IVC Verru... | paclitaxel carboplatin intensity-modul... quality-of-life... | 19 Years - | Jonsson Comprehensive Cancer Center | |
| Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection | NCT03202992 | HSIL, High-Grad... Human Papilloma... HIV Infection Anal Cancer Anus Neoplasms | ABI-1968 | 27 Years - | Antiva Biosciences | |
| Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV | NCT01946139 | Anal Cancer HIV Infection Human Papilloma... | comparison of s... laboratory biom... questionnaire a... quality-of-life... | 18 Years - | AIDS Malignancy Consortium | |
| Folic Acid Clinical Trial for the Prevention of Cervical Cancer | NCT00703196 | Cervical Cancer Precancerous Co... | folic acid placebo | 19 Years - 120 Years | University of Alabama at Birmingham | |
| Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening | NCT00977392 | Health Status U... Precancerous Co... | compliance moni... cervical Papani... educational int... screening quest... survey administ... colposcopy | 25 Years - | National Cancer Institute (NCI) | |
| A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts | NCT02015260 | Anogenital Wart... Condylomata Acu... | Topical NO Placebo | 18 Years - | University of Aberdeen | |
| The Parents in Appalachia Receive Education Needed for Teen Project | NCT01901770 | Healthy Human Papilloma... | educational int... educational int... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia | NCT00060099 | Precancerous Co... | HspE7 | 18 Years - | National Cancer Institute (NCI) | |
| Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia | NCT01164722 | Anal Cancer Neoplasm of Unc... Nonneoplastic C... Precancerous Co... | clinical observ... infrared photoc... | 27 Years - | AIDS Malignancy Consortium | |
| Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System | NCT01446198 | Human Papilloma... | 18 Years - | Gen-Probe, Incorporated | ||
| Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer | NCT02258659 | Human Papilloma... Stage III Squam... Stage IVA Squam... Stage IVB Squam... | paclitaxel albu... carboplatin radiation thera... paclitaxel fluorouracil hydroxyurea cisplatin laboratory biom... quality-of-life... | 18 Years - | University of Chicago | |
| The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia | NCT00653146 | Cervical Cancer Precancerous Co... | Mindfulness-Bas... Healthy Lifesty... | 18 Years - | Fox Chase Cancer Center | |
| Developing Methods to Investigate Additional Opportunities of HPV Vaccination by Using First-void Urine Samples | NCT04391647 | Human Papilloma... | First-void urin... Blood draw | 18 Years - 25 Years | Universiteit Antwerpen | |
| Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With Men | NCT00955591 | Anal Cancer Nonneoplastic C... Precancerous Co... | Papanicolaou te... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer | NCT01898494 | Human Papilloma... Stage III Squam... Stage IVA Squam... Stage IVB Squam... | Transoral surge... intensity-modul... cisplatin carboplatin | 18 Years - | Eastern Cooperative Oncology Group | |
| Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions. | NCT04199078 | Human Papilloma... Human Papilloma... Cervix Lesion | Papilocare vagi... | 30 Years - 65 Years | Procare Health Iberia S.L. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
